Qiuyan Guo
No ORCID on file
· 7 papers in corpus
· active 2017-2025
Study types
- article 5
- other 1
- preprint 1
Condition tags
- endometriosis 7
- mesh:D004715 4
- infertility 3
- dysmenorrhea 1
- chronic_pelvic_pain 1
Top journals
Frequent coauthors
- Guangmei Zhang 7
- Yulei Cheng 7
- Tian Liang 6
- Liyuan Sun 5
- Jing Wang 5
- Han Wu 5
- Xiaotong Wang 4
- Xibo Zhao 3
- Yanan He 2
- Dejun Wang 2
other
2025
Endometriosis is a chronic inflammatory and neoangiogenic disease. Endostatin is one of the most effective inhibitors of angiogenesis. Mesenchymal stem cells (MSCs) have been investigated as compelling options for cell therapy. However, the…
article
2023
An RNA modification known as N6-methyladenosine (m6A) interacts with a range of coding and non-coding RNAs. The majority of the research has focused on identifying m6A regulators that are differentially expressed in endometriosis, but it ha…
article
2023
BACKGROUND: Endometriosis (EMs), the ectopic planting of functional endometrium outside of the uterus, is a leading cause of infertility and pelvic pain. As a fundamental mRNA modification, N6-methyladenosine (m6A) participates in various p…
preprint
2022
Abstract Background An RNA modification known as n6-methyladenosine (m6A) interacts with a range of coding and non-coding RNAs. The majority of research focused on identifying m6A regulators that are differentially expressed in endometriosi…
article
2021
Background: Endometriosis is interpreted as the existence of endometrium outside the uterine cavity, such as ovaries, fallopian tubes and pelvic cavity. Dysmenorrhea, abnormal menstruation, infertility, and chronic pelvic pain are the prima…
article
2018
article
2017
Human endometrial tissue has become an attractive source of mesenchymal stem cells (MSCs) for cell-based therapies because these MSCs can be easily harvested and have tumour tropism as well as reduced immunogenic and inflammatory properties…